CEL-SCI Corporation (NYSE MKT: CVM) announced today that during its annual Shareholder's Meeting on June 12, 2017, a 1-for-25 reverse split was authorized for its outstanding shares of common stock. CEL-SCI expects the split to be …
TMCnet10mon
Cel-Sci - entered definitive agreement with one institutional investor for offering of shares of stock with proceeds of about $1.51 million in direct offering * Cel-Sci corp- intends to use net proceeds from offering for phase 3 clinical study and …
Reuters11mon
You can’t win with the tabloids. You’re either too fat, too thin, or hiding a deadly secret. This week’s tabloids continue their obsession with the stars’ weight, led by the ‘National Enquirer’ and its team of reporters expertly trained by ...
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT:CVM) announced today that it has priced its public offering of common stock and warrants. CEL-SCI announced that it has agreed to sell 34,024,000 shares of
Present at the listing ceremony were Chen Shuang, Executive Director and CEO of China Everbright Limited ("CEL";
* Cel-Sci Corp - a 1-for-25 reverse split was authorized for its outstanding shares of common stock Source text for Eikon: Further company coverage: